Curated News
By: NewsRamp Editorial Staff
September 29, 2026
Creative Biolabs Links Glycoprotein Development with Glycan Analysis
TLDR
- Creative Biolabs integrates glycoprotein development with glycan analysis, giving researchers a competitive edge in optimizing therapeutic candidates.
- Creative Biolabs uses HPAE-PAD, HPLC, CE, MS, NMR, and SEC to characterize glycans and link production conditions to molecular attributes.
- Creative Biolabs' integrated glycoprotein services help researchers develop safer and more effective therapeutics, improving future patient outcomes.
- Glycosylation can vary with expression systems, affecting protein stability and activity, so Creative Biolabs offers tailored analytical strategies.
Impact - Why it Matters
This news matters because glycosylation is a critical quality attribute that can affect the safety, efficacy, and stability of therapeutic glycoproteins. By integrating development and characterization, Creative Biolabs is helping researchers move beyond a one-size-fits-all approach to glycan analysis. The ability to tailor analytical strategies to specific molecules and research questions can lead to more efficient development, better understanding of production-related variation, and ultimately more robust biotherapeutics. As the biopharmaceutical industry continues to advance complex glycoprotein drugs, access to comprehensive glycan characterization services will be essential for ensuring product consistency and meeting regulatory expectations.
Summary
Creative Biolabs is connecting molecular design and production with glycoprotein characterization and glycan analysis through its integrated glycoprotein development capabilities. The company emphasizes that developing a therapeutic glycoprotein requires more than producing the correct amino acid sequence; glycosylation can vary with expression systems and production conditions, introducing molecular heterogeneity that may influence protein stability, biological activity, and other molecular properties. As candidates progress through development, researchers need analytical strategies that link production decisions with glycan-level characterization.
To support this, Creative Biolabs offers a range of analytical approaches, including carbohydrate analysis services that can assess overall carbohydrate composition, quantify constituent monosaccharides, compare glycosylation profiles, or investigate glycan structures in greater detail. Depending on the research question, methods such as high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD), high-performance liquid chromatography (HPLC), capillary electrophoresis (CE), mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and size-exclusion chromatography (SEC) can be combined to provide complementary layers of compositional and structural information. The company also highlights monosaccharide composition analysis as an initial step when production batches exhibit different glycosylation profiles, followed by additional glycan and structural analyses to investigate variation. This question-driven approach helps researchers select analytical technologies according to specific development challenges rather than applying the same workflow to every candidate. Creative Biolabs provides biotechnology research services spanning therapeutic discovery, glycoprotein development, glycoengineering, production, and advanced characterization for pharmaceutical, biotechnology, and academic organizations worldwide.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, Creative Biolabs Links Glycoprotein Development with Glycan Analysis
